File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Gas station in blood vessels: An endothelium mimicking, self-sustainable nitric oxide fueling stent coating for prevention of thrombosis and restenosis

TitleGas station in blood vessels: An endothelium mimicking, self-sustainable nitric oxide fueling stent coating for prevention of thrombosis and restenosis
Authors
KeywordsAnti-restenosis
Anti-thrombosis
Cardiovascular stent coating
Endothelium-mimicking
Long-term nitric oxide production
Issue Date1-Nov-2023
PublisherElsevier
Citation
Biomaterials, 2023, v. 302 How to Cite?
Abstract

Stenting is the primary treatment for vascular obstruction-related cardiovascular diseases, but it inevitably causes endothelial injury which may lead to severe thrombosis and restenosis. Maintaining nitric oxide (NO, a vasoactive mediator) production and grafting endothelial glycocalyx such as heparin (Hep) onto the surface of cardiovascular stents could effectively reconstruct the damaged endothelium. However, insufficient endogenous NO donors may impede NO catalytic generation and fail to sustain cardiovascular homeostasis. Here, a dopamine-copper (DA-Cu) network-based coating armed with NO precursor L-arginine (Arg) and Hep (DA-Cu-Arg-Hep) is prepared using an organic solvent-free dipping technique to form a nanometer-thin coating onto the cardiovascular stents. The DA-Cu network adheres tightly to the surface of stents and confers excellent NO catalytic activity in the presence of endogenous NO donors. The immobilized Arg functions as a NO fuel to generate NO via endothelial nitric oxide synthase (eNOS), while Hep works as eNOS booster to increase the level of eNOS to decompose Arg into NO, ensuring a sufficient supply of NO even when endogenous donors are insufficient. The synergistic interaction between Cu and Arg is analogous to a gas station to fuel NO production to compensate for the insufficient endogenous NO donor in vivo. Consequently, it promotes the reconstruction of natural endothelium, inhibits smooth muscle cell (SMC) migration, and suppresses cascading platelet adhesion, preventing stent thrombosis and restenosis. We anticipate that our DA-Cu-Arg-Hep coating will improve the quality of life of cardiovascular patients through improved surgical follow-up, increased safety, and decreased medication, as well as revitalize the stenting industry through durable designs.


Persistent Identifierhttp://hdl.handle.net/10722/346160
ISSN
2023 Impact Factor: 12.8
2023 SCImago Journal Rankings: 3.016

 

DC FieldValueLanguage
dc.contributor.authorRao, Jingdong-
dc.contributor.authorMou, Xiaohui-
dc.contributor.authorMo, Yongyi-
dc.contributor.authorBei, Ho Pan-
dc.contributor.authorWang, Li-
dc.contributor.authorTang, Chuyang Y-
dc.contributor.authorYiu, Kai Hang-
dc.contributor.authorYang, Zhilu-
dc.contributor.authorZhao, Xin-
dc.date.accessioned2024-09-12T00:30:35Z-
dc.date.available2024-09-12T00:30:35Z-
dc.date.issued2023-11-01-
dc.identifier.citationBiomaterials, 2023, v. 302-
dc.identifier.issn0142-9612-
dc.identifier.urihttp://hdl.handle.net/10722/346160-
dc.description.abstract<p>Stenting is the primary treatment for vascular obstruction-related cardiovascular diseases, but it inevitably causes endothelial injury which may lead to severe thrombosis and restenosis. Maintaining nitric oxide (NO, a vasoactive mediator) production and grafting endothelial glycocalyx such as heparin (Hep) onto the surface of cardiovascular stents could effectively reconstruct the damaged endothelium. However, insufficient endogenous NO donors may impede NO catalytic generation and fail to sustain cardiovascular homeostasis. Here, a dopamine-copper (DA-Cu) network-based coating armed with NO precursor L-arginine (Arg) and Hep (DA-Cu-Arg-Hep) is prepared using an organic solvent-free dipping technique to form a nanometer-thin coating onto the cardiovascular stents. The DA-Cu network adheres tightly to the surface of stents and confers excellent NO catalytic activity in the presence of endogenous NO donors. The immobilized Arg functions as a NO fuel to generate NO via endothelial nitric oxide synthase (eNOS), while Hep works as eNOS booster to increase the level of eNOS to decompose Arg into NO, ensuring a sufficient supply of NO even when endogenous donors are insufficient. The synergistic interaction between Cu and Arg is analogous to a gas station to fuel NO production to compensate for the insufficient endogenous NO donor in vivo. Consequently, it promotes the reconstruction of natural endothelium, inhibits smooth muscle cell (SMC) migration, and suppresses cascading platelet adhesion, preventing stent thrombosis and restenosis. We anticipate that our DA-Cu-Arg-Hep coating will improve the quality of life of cardiovascular patients through improved surgical follow-up, increased safety, and decreased medication, as well as revitalize the stenting industry through durable designs.</p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofBiomaterials-
dc.subjectAnti-restenosis-
dc.subjectAnti-thrombosis-
dc.subjectCardiovascular stent coating-
dc.subjectEndothelium-mimicking-
dc.subjectLong-term nitric oxide production-
dc.titleGas station in blood vessels: An endothelium mimicking, self-sustainable nitric oxide fueling stent coating for prevention of thrombosis and restenosis-
dc.typeArticle-
dc.identifier.doi10.1016/j.biomaterials.2023.122311-
dc.identifier.pmid37677916-
dc.identifier.scopuseid_2-s2.0-85169840100-
dc.identifier.volume302-
dc.identifier.eissn1878-5905-
dc.identifier.issnl0142-9612-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats